3 mg per kilogram (kg) of body weight per day, divided and taken 3 or 4 times a day
Your child should not chew the tablets
A definitive randomised controlled trial of dexamethasone, started in infants at high risk between 7 and 14 days at a lower dose than usual, now merits special
November 06, 2020 The results of a new clinical trial, published on October 23, 2020, in the New England Journal of Medicine, show that dexamethasone, a glucocorticoid, can
The primary corticosteroids utilized for the anti-inflammatory effects in infants with BPD include hydrocortisone, dexamethasone, prednisolone, and
Postnatal corticosteroids (PCSs) are a proven therapy for CLD but carry substantial risk
A total of 133 children (70 in the control group, 63 in the dexamethasone-treated group) who survived
It accounts for 7% of hospitalizations annually for fever and/or acute respiratory illness in It has been commonly described with oral and topical steroid use, but scarce reports have documented intranasal steroid usage as the etiology in infancy
Fast, slow, or abnormal heartbeat
After giving this drug, ask your child to keep eyes closed
Although other corticosteroids, such as betamethasone and fludrocortisone, have been considered, there are limited and variable data available to
8%) were exposed by day 28 after birth
10–100 micrograms/kg daily in 1–2 divided doses, adjusted according to response; up to 300 micrograms/kg daily may be required in emergency situations
2004;69 (2):325-330
Objective To assess the efficacy of oral dexamethasone or nebulized dexamethasone sodium phosphate in children with mild croup
Antepartum dexamethasone administration was associated with a significant lowering of the incidence of respiratory distress syndrome (RDS) and with marked reduction of early neonatal mortality in premature infants
3 mg/kg PO divided in equal doses every 12 hr to a school-age child who weighs 50 lb
Question What are the patterns of dexamethasone and prednisolone and methylprednisolone use in extremely preterm infants and are their use associated with 2-year outcomes?